Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression

被引:83
|
作者
Niciu, Mark J. [1 ]
Shovestul, Bridget J. [1 ]
Jaso, Brittany A. [2 ]
Farmer, Cristan [1 ]
Luckenbaugh, David A. [3 ]
Brutsche, Nancy E. [1 ]
Park, Lawrence T. [1 ]
Ballard, Elizabeth D. [1 ]
Zarat, Carlos A., Jr. [1 ]
机构
[1] NIMH, NIH, Expt Therapeut & Pathophysiol Branch, Bldg 10 CRC,10 Ctr Dr,Unit 7 Southeast, Bethesda, MD 20892 USA
[2] Univ Miami, Dept Psychol, POB 248185-0751, Coral Gables, FL 33124 USA
[3] NIH, Off Equ Divers & Inclus, 2115 E Jefferson St, Rockville, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Dissociation; Ketamine; Depression; METHYL-D-ASPARTATE; ADD-ON TRIAL; MAJOR DEPRESSION; BIPOLAR DEPRESSION; PREFRONTAL CORTEX; RANDOMIZED-TRIAL; DOUBLE-BLIND; ANTAGONIST; GLUTAMATE; BLOCKADE;
D O I
10.1016/j.jad.2018.02.049
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Ketamine induces rapid and robust antidepressant effects, and many patients also describe dissociation, which is associated with antidepressant response. This follow-up study investigated whether antidepressant efficacy is uniquely related to dissociative symptom clusters. Methods: Treatment-resistant patients with major depressive disorder (MDD) or bipolar disorder (BD) (n=126) drawn from three studies received a single subanesthetic (0.5 mg/kg) ketamine infusion. Dissociative effects were measured using the Clinician-Administered Dissociative States Scale (CADSS). Antidepressant response was measured using the 17-item Hamilton Depression Rating Scale (HAM-D). A confirmatory factor analysis established the validity of CADSS subscales (derealization, depersonalization, amnesia), and a general linear model with repeated measures was fitted to test whether subscale scores were associated with antidepressant response. Results: Factor validity was supported, with a root mean square error of approximation of .06, a comparative fit index of .97, and a Tucker-Lewis index of .96. Across all studies and timepoints, the depersonalization subscale was positively related to HAM-D percent change. A significant effect of derealization on HAM-D percent change was observed at one timepoint (Day 7) in one study. The amnesia subscale was unrelated to HAM-D percent change. Limitations: Possible inadequate blinding; combined MDD/BD datasets might have underrepresented ketamine's antidepressant efficacy; the possibility of Type I errors in secondary analyses. Conclusions: From a psychometric perspective, researchers may elect to administer only the CADSS depersonalization subscale, given that it was most closely related to antidepressant response. From a neurobiological perspective, mechanistic similarities may exist between ketamine-induced depersonalization and antidepressant response, although off-target effects cannot be excluded.
引用
收藏
页码:310 / 315
页数:6
相关论文
共 50 条
  • [41] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    [J]. PHARMACEUTICALS, 2021, 14 (05)
  • [42] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [43] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
    Cullen, Kathryn R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
  • [44] Clinical Efficacy of Ketamine for Treatment-resistant Depression
    Bratsos, Sosipatros
    Saleh, Sohag N.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [45] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [46] Oral ketamine for the treatment of pain and treatment-resistant depression
    Schoevers, Robert A.
    Chaves, Tharcila V.
    Balukova, Sonya M.
    aan het Rot, Marije
    Kortekaas, Rudie
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (02) : 108 - 113
  • [47] Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression
    Calati, R.
    Massat, I.
    Kasper, S.
    Montgomery, S.
    Zohar, J.
    Mendlewicz, J.
    Serretti, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S74 - S74
  • [48] Can 'floating' predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression
    Acevedo-Diaz, Elia E.
    Cavanaugh, Grace W.
    Greenstein, Dede
    Kraus, Christoph
    Kadriu, Bashkim
    Park, Lawrence
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2020, 130 : 280 - 285
  • [49] Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
    Carlson, Paul J.
    Diazgranados, Nancy
    Nugent, Allison C.
    Ibrahim, Lobna
    Luckenbaugh, David A.
    Brutsche, Nancy
    Herscovitch, Peter
    Manji, Husseini K.
    Zarate, Carlos A., Jr.
    Drevets, Wayne C.
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (12) : 1213 - 1221
  • [50] Maintenance of antidepressant effect by dextromethorphan in patients with treatment-resistant depression who respond to ketamine intervention
    Chen, Mu-Hong
    Tsai, Shih-Jen
    [J]. MEDICAL HYPOTHESES, 2024, 182